Yüklüyor......
Could Mesenchymal Stem Cell-Derived Exosomes Be a Therapeutic Option for Critically Ill COVID-19 Patients?
Coronavirus disease 2019 (COVID-19) is a pandemic viral disease originated in Wuhan, China, in December 2019, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The severe form of the disease is often associated with acute respiratory distress syndrome (ARDS), and most criti...
Kaydedildi:
| Yayımlandı: | J Clin Med |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7565764/ https://ncbi.nlm.nih.gov/pubmed/32858940 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9092762 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|